Cargando…

Novel targets for Huntington’s disease: future prospects

Huntington’s disease (HD) is an incurable, inherited, progressive, neurodegenerative disorder that is characterized by a triad of motor, cognitive, and psychiatric problems. Despite the noticeable increase in therapeutic trials in HD in the last 20 years, there have, to date, been very few significa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mason, Sarah L, Barker, Roger A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053088/ https://www.ncbi.nlm.nih.gov/pubmed/30050366 http://dx.doi.org/10.2147/DNND.S83808

Ejemplares similares

Problems with Social Cognition and Decision-Making in Huntington’s Disease: Why Is it Important?
por: Mason, Sarah L., et al.
Publicado: (2021)

Sleep Dysfunction in Huntington’s Disease: Impacts of Current Medications and Prospects for Treatment
por: Owen, Natalia E., et al.
Publicado: (2023)

Exploring the predictors of financial impairment in Huntington’s disease using the Enroll-HD dataset
por: Harris, Kate L., et al.
Publicado: (2022)

Metacognitive insight into cognitive performance in Huntington’s disease gene carriers
por: Hewitt, Samuel RC, et al.
Publicado: (2022)

Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Huntington’s Disease
por: Collins, Lucy M., et al.
Publicado: (2015)

The Clinical Features and Progression of Late-Onset Versus Younger-Onset in an Adult Cohort of Huntington’s Disease Patients
por: Anil, Megha, et al.
Publicado: (2020)

Serum Raman spectroscopy as a diagnostic tool in patients with Huntington's disease
por: Huefner, Anna, et al.
Publicado: (2019)

Predicting clinical diagnosis in Huntington's disease: An imaging polymarker
por: Mason, Sarah L., et al.
Publicado: (2018)

Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)
por: Harris, Kate L, et al.
Publicado: (2020)

Targets for future clinical trials in Huntington's disease: What's in the pipeline?
por: Wild, Edward J, et al.
Publicado: (2014)

Platelet abnormalities in Huntington’s disease
por: Denis, Hélèna L, et al.
Publicado: (2019)

Current and Possible Future Therapeutic Options for Huntington’s Disease
por: Ferguson, Mackenzie W., et al.
Publicado: (2022)

Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives
por: García-González, Xandra, et al.
Publicado: (2023)

Targeting the Cholinergic System to Develop a Novel Therapy for Huntington’s Disease
por: D’Souza, Gary X., et al.
Publicado: (2016)

The role of the amygdala during emotional processing in Huntington's disease: From pre-manifest to late stage disease
por: Mason, Sarah L., et al.
Publicado: (2015)

Cognitive follow up of a small cohort of Huntington’s disease patients over a 5 year period.
por: Mason, Sarah L, et al.
Publicado: (2010)

Sleep deficits but no metabolic deficits in premanifest Huntington's disease
por: Lazar, Alpar S., et al.
Publicado: (2015)

The Current Status of Neural Grafting in the Treatment of Huntington’s Disease. A Review
por: Wijeyekoon, Ruwani, et al.
Publicado: (2011)

Targeting Huntington’s disease through histone deacetylases
por: Gray, Steven G.
Publicado: (2011)

Absence of Acanthocytosis in Huntington’s Disease-like 2: A Prospective Comparison with Huntington’s Disease
por: Anderson, David G., et al.
Publicado: (2017)

An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington’s disease
por: Underwood, Benjamin R., et al.
Publicado: (2017)

Purine Nucleotides Metabolism and Signaling in Huntington’s Disease: Search for a Target for Novel Therapies
por: Tomczyk, Marta, et al.
Publicado: (2021)

Current Pharmacological Management in Juvenile Huntington’s Disease
por: Robertson, Lisa, et al.
Publicado: (2012)

Hydrocephalus Complicating Intrathecal Antisense Oligonucleotide Therapy for Huntington's Disease
por: Stoker, Thomas B., et al.
Publicado: (2020)

Outcome of cell suspension allografts in a patient with Huntington's disease
por: Maxan, Alexander, et al.
Publicado: (2018)

A Touchscreen Motivation Assessment Evaluated in Huntington's Disease Patients and R6/1 Model Mice
por: Heath, Christopher J., et al.
Publicado: (2019)

Identifying sleep disturbances in Huntington’s disease using a simple disease-focused questionnaire
por: Goodman, Anna O. G., et al.
Publicado: (2010)

Body composition in premanifest Huntington’s disease reveals lower bone density compared to controls.
por: Goodman, Anna O. G., et al.
Publicado: (2011)

Irritability in Huntington’s Disease
por: Karagas, Nicholas E., et al.
Publicado: (2020)

Glycation in Huntington’s Disease: A Possible Modifier and Target for Intervention
por: Brás, Inês Caldeira, et al.
Publicado: (2019)

The Neurodevelopmental Hypothesis of Huntington’s Disease
por: van der Plas, Ellen, et al.
Publicado: (2020)

A retrospective analysis of hand tapping as a longitudinal marker of disease progression in Huntington’s disease
por: Collins, Lucy M, et al.
Publicado: (2014)

Targeting the proteostasis network in Huntington’s disease
por: Soares, Tânia R., et al.
Publicado: (2019)

A Novel Huntington’s Disease Assessment Platform to Support Future Drug Discovery and Development
por: Wu, Jingyun, et al.
Publicado: (2022)

Huntington’s Disease: The Past, Present, and Future Search for Disease Modifiers
por: Clabough, Erin B.D.
Publicado: (2013)

Huntington Disease in Asia
por: Xu, Miao, et al.
Publicado: (2015)

Mitochondria in Huntington’s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies
por: Jurcau, Anamaria, et al.
Publicado: (2022)

Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
por: Di Pardo, Alba, et al.
Publicado: (2017)

Neural and mesenchymal stem cells in animal models of Huntington’s disease: past experiences and future challenges
por: Kerkis, Irina, et al.
Publicado: (2015)

Therapeutic Strategies in Huntington's Disease
por: Kanazawa, Ichiro
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_lminvgrvgfe55qm9hskgk5lsoe